London-headquartered chocolates-to-beverages multinational Cadbury Schweppes has agreed with US pharmaceuticals giant Pfizer to acquire its iconic Adams chewing gum brands – the planet’s second largest such business after Wrigley’s.

The $4.2 billion (€4.08; £2.6bn) deal, which significantly hikes Cadbury’s presence in the US and Latin America, is further sweetened by the addition of other Adams goodies such as Hall’s cough candies and breath freshener brands Certs and Clorets.

Cadbury, which paid over the odds according to some US analysts who value Adams at around $4bn, bested bids by Nestlé and Kraft Foods.

Data sourced from: BBC Online Business News (UK); additional content by WARC staff